Indica Labs Introduces HALO AI Apps for Enhanced Life Sciences Image Analysis
Indica Labs has launched a new suite of HALO AI Apps, expanding their AI capabilities for life sciences. These pre-trained …
News
Pathos AI Acquires Brain-Penetrant PRMT5 Inhibitor for Precision Cancer Therapy
Pathos AI has announced the acquisition of a worldwide license for PRT811, a SAM-competitive PRMT5 inhibitor, from Prelude Therapeutics. Renamed …
Pfizer Appoints New Chief AI Officer to Enhance Digital Innovation
As Amber Jackson reports for Technology Magazine, Pfizer has appointed Berta Rodriguez-Hervas as its new Chief AI and Analytics Officer, …
23andMe Shifts Focus to Telehealth GLP-1 Prescriptions Amid Strategic Realignment
Consumer genetic testing company 23andMe has announced a strategic shift, closing its drug discovery division while expanding into the rapidly …
Medable Introduces New eCOA Platform to Streamline Clinical Trial Launches
Medable Inc., a technology platform provider specializing in clinical trials, has announced the launch of Medable Studio, an all-in-one application …
Basecamp Research Partners with Cameroon to Share Benefits from Genetic Data Use in Landmark Agreement
Basecamp Research, a London-based biotech company specializing in AI-driven design of proteins and other biological systems, has entered into a …
Veridix AI Introduces Protocol Digitization to Streamline Clinical Trial Study Builds
Veridix AI, a subsidiary of the Emmes Group, has unveiled its latest technological advancement aimed at enhancing the efficiency of …
OpenFold Consortium Expands with Six New Members to Strengthen Open-Source AI Tools for Drug Discovery
OpenFold, a prominent non-profit AI research consortium dedicated to developing free and open-source tools for biology and drug discovery, has …
Persist AI and Nivagen Collaborate on AI-Enhanced Manufacturing for Long-Acting Injectables
Persist AI and Nivagen have announced a strategic collaboration aimed at advancing the manufacturing process for long-acting injectable (LAI) drugs. …
Halda Therapeutics Secures $126 Million in Series B Extension to Advance RIPTAC Cancer Therapies
Halda Therapeutics, a biotechnology company specializing in cancer treatments, has announced the successful completion of a $126 million Series B …
Novel AI Framework for Detecting LLM "Hallucinations" in Medical Summaries
Mendel AI, a startup specializing in healthcare artificial intelligence (AI), in collaboration with the University of Massachusetts Amherst (UMass Amherst), …
Roche Arguably Weighs Sale of Its Health Data Subsidiary Amid Strategic Challenges: A $1.9 Billion Gamble in Question
Roche is reportedly considering the sale of Flatiron Health, a cancer data specialist that it acquired for $1.9 billion in …